PURE BIOSCIENCE IN COM NPV (PURE)

0.98
0.02 2.00
OTC
Prev Close 1.00
Open 1.00
Day Low/High 0.96 / 1.00
52 Wk Low/High 0.75 / 1.28
Volume 24.84K
Exchange OTC
Shares Outstanding 62.60B
Market Cap 61.35M
Div & Yield N.A. (N.A)

Latest News

PURE Bioscience Receives USDA Permission Letter And FDA FCN Acknowledgement Letter

PURE Bioscience Receives USDA Permission Letter And FDA FCN Acknowledgement Letter

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced that the Company has received two required key regulatory notifications on the Company's path...

PURE Bioscience Receives First Order For PURE Control® Antimicrobial From A Leading Produce Processor

PURE Bioscience Receives First Order For PURE Control® Antimicrobial From A Leading Produce Processor

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced that the Company had received and shipped its first order for FDA approved PURE...

PURE Bioscience Reports Improved 2017 Fiscal Second Quarter And Six-Month Financial Results

PURE Bioscience Reports Improved 2017 Fiscal Second Quarter And Six-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal second quarter and six-month periods ended...

PureCircle Completes $42m Stevia Plant Expansion

PureCircle Completes $42m Stevia Plant Expansion

-Doubles Capacity to Extract High Quality, Sustainable Stevia

PURE Bioscience To Present At The 29th Annual ROTH Capital Partners Conference

PURE Bioscience To Present At The 29th Annual ROTH Capital Partners Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today the Company will present at the 29th Annual ROTH Capital Partners Conference on March...

PURE Bioscience Sets Q2 Results Conference Call To Review Sales And Progress Of Its SDC-Based Antimicrobial Food Safety Solutions Strategy

PURE Bioscience Sets Q2 Results Conference Call To Review Sales And Progress Of Its SDC-Based Antimicrobial Food Safety Solutions Strategy

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that the Company will publish fiscal Q2 results after the market closes and host an...

PURE Bioscience Receives FDA Interim Safety Determination Authorization To Test Higher Concentrations Of SDC-Based PURE Control® Antimicrobial As A Poultry Processing Aid

PURE Bioscience Receives FDA Interim Safety Determination Authorization To Test Higher Concentrations Of SDC-Based PURE Control® Antimicrobial As A Poultry Processing Aid

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the non-toxic, patented silver dihydrogen citrate ( SDC) antimicrobial, today announced the Company had received a Preliminary Notification (PNC) authorization letter...

Recent Norovirus Outbreaks In National Media Headlines - Highly Effective PURE® Hard Surface Disinfectant Kills Norovirus In 60 Seconds

Recent Norovirus Outbreaks In National Media Headlines - Highly Effective PURE® Hard Surface Disinfectant Kills Norovirus In 60 Seconds

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, has published a Norovirus Technical Bulletin highlighting the unique and powerful effectiveness of...

PURE Bioscience Well Positioned To Provide Solutions To 2017's Key Food Safety Challenges

PURE Bioscience Well Positioned To Provide Solutions To 2017's Key Food Safety Challenges

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, discusses the Company's positioning to address the major food safety challenges faced by food manufacturers and...

PURE Bioscience Reports Q1 2017 Financial Results

PURE Bioscience Reports Q1 2017 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2016.

PURE Bioscience Sets Fiscal 2017 Q1 Results Conference Call

PURE Bioscience Sets Fiscal 2017 Q1 Results Conference Call

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today that on December 14, 2016 the Company will file its Form 10-Q shortly after the close of the...

PURE Bioscience Reports Fiscal 2016 Year-End Financial Results

PURE Bioscience Reports Fiscal 2016 Year-End Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal year ended July 31, 2016.

PURE Bioscience To Host Fiscal 2016 Year-End Financial Results Conference Call

PURE Bioscience To Host Fiscal 2016 Year-End Financial Results Conference Call

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today that on October 27, 2016 the Company will file its Form 10-K shortly after the close of the...

PURE® Hard Surface Disinfectant Included In Chipotle's Enhanced Restaurant Procedures

PURE® Hard Surface Disinfectant Included In Chipotle's Enhanced Restaurant Procedures

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced that Chipotle Mexican Grill, Inc.

New Processing Plant Built To Double PureCircle's Stevia Production

New Processing Plant Built To Double PureCircle's Stevia Production

Expected To Open In 2017, Will Have Line Dedicated To High-Demand Ingredients

Four Leading Produce Processors Now Conducting Use Trials With FDA Approved PURE Control® To Prevent Foodborne Illness

Four Leading Produce Processors Now Conducting Use Trials With FDA Approved PURE Control® To Prevent Foodborne Illness

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today provided an update on the commercialization efforts of FDA approved PURE Control® as a food safety...

Two National Restaurant Chains Adopt PURE® Hard Surface Disinfectant As A Food Safety Solution

Two National Restaurant Chains Adopt PURE® Hard Surface Disinfectant As A Food Safety Solution

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced that it had shipped orders for SDC-based PURE® Hard Surface disinfectant to two national...

PURE Bioscience To Present At Rodman & Renshaw's 2016 Annual Global Investment Conference On September 13th

PURE Bioscience To Present At Rodman & Renshaw's 2016 Annual Global Investment Conference On September 13th

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today the Company will present at Rodman & Renshaw's 2016 Annual Global Investment Conference on...

PureCircle Announces $100 Million Investment In Agronomy Program

PureCircle Announces $100 Million Investment In Agronomy Program

Expands Stevia Farming To New Regions Allowing For 10,000 Hectare Pipeline

PURE Bioscience Receives USDA No Objection Letter For Use Of SDC-Based PURE Control® Antimicrobial In Poultry Processing For Pre-OLR And Post Chill Applications

PURE Bioscience Receives USDA No Objection Letter For Use Of SDC-Based PURE Control® Antimicrobial In Poultry Processing For Pre-OLR And Post Chill Applications

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced that it received a "No Objection Letter" from the USDA's Food Safety and Inspection Service...

PURE® Hard Surface Disinfectant - Expands Its Reach In Restaurant Industry

PURE® Hard Surface Disinfectant - Expands Its Reach In Restaurant Industry

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced that it has initiated operational testing of PURE® Hard Surface disinfectant with a...

PURE Bioscience Reports 2016 Fiscal Third Quarter And Nine-Month Financial Results

PURE Bioscience Reports 2016 Fiscal Third Quarter And Nine-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal third quarter and nine-month periods ended April 30, 2016.

OTCQX And OTCQB Companies To Present At 2016 Marcum MicroCap Conference

OTCQX And OTCQB Companies To Present At 2016 Marcum MicroCap Conference

OTC Markets Group, President and CEO R. Cromwell Coulson, will speak on panel "Understanding Reg A+ and the 'Mini IPO'"

PURE Bioscience Raises $1.27 Million From Warrant Exercise

PURE Bioscience Raises $1.27 Million From Warrant Exercise

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today that the Company raised $1.

PURE Bioscience Sets Q3 Results Conference Call To Update Progress Of FDA Approved PURE Control® Antimicrobial And The Company's Food Safety Solutions Strategy

PURE Bioscience Sets Q3 Results Conference Call To Update Progress Of FDA Approved PURE Control® Antimicrobial And The Company's Food Safety Solutions Strategy

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today that on June 9, 2016 the Company will file its Form 10-Q shortly after the close of the market...

PURE Bioscience To Present At The 2016 Marcum MicroCap Conference On June 2nd

PURE Bioscience To Present At The 2016 Marcum MicroCap Conference On June 2nd

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today the Company will present at the 2016 Marcum MicroCap Conference at 11:30am EDT on Thursday,...

PURE Bioscience To Present At The Joseph Gunnar

PURE Bioscience To Present At The Joseph Gunnar "Pioneers 2016" Conference On May 5th

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today the Company will present at the Joseph Gunnar "Pioneers 2016" Conference on May 5, 2016 at the...